News Current page: 8

Tübingen, 3 November 1906: Alzheimer’s disease described for the first time 3 November 1906 is an important date in the history of Alzheimer’s disease. For on this Saturday, the physician Dr. Alois Alzheimer (14.6.1864 – 19.12.1915) described a type of dementia disease for the first time at a specialist conference at the Tübingen Nervenklinik. Alzheimer, […]

In our series “SHS portfolio companies”, today we talk to Reinhold Blazejewski, founder and managing partner of Blazejewski MEDI-TECH GmbH, which produces high-tech endoscopes as an OEM manufacturer for the global market in Sexau, Baden. SHS has held a stake in the MedTech SME since January 2020. Reinhold Blazejewski is what is called a tinkerer […]

With the CARLO® surgical robot for high-precision laser cutting of bones, the Swiss medical robotics company AOT has already made technological history in the operating theatre. More than 80 procedures have already been successfully performed on patients with CARLO®. The system is CE-certified for all of Europe. Now the medical robotics experts at AOT have […]

SHS enjoys a very good reputation as a specialised healthcare investor among companies and institutional investors because it draws on a strong network of experts. The medical-technical healthcare experts who support SHS and the portfolio companies play a special role here. Professor Dr Arnulf Stenzl has been Medical Director of the Department of Urology at […]

The medical technology industry has not exactly had it easy in the last two years. In addition to the pandemic, which has shaken the industry, the MDR (Medical Device Regulation) of the EU and digitalisation in particular present companies with major challenges that tie up manpower and capital. In addition, there are now pandemic-related supply […]

Here we introduce you to the SHS senior advisors. The experience of these experts plays an important role for us in the investment process and benefits not least our portfolio companies. Professor Dr. rer. nat. Armin Bolz was Professor of Biomedical Engineering at KIT from 1999 to 2013. At the same time, he founded and […]

Founded in 2013, our portfolio company Lowenco is already one of the leading providers of ultra-low temperature solutions for the global biopharma industry after just a few years. A success that is also reflected in the company’s books. As of 31.12.2021, Lowenco reports an increase in operating profit of around 32 percent to now 80 […]

SHS is pleased to offer students a practical experience within the framework of an internship and to give them an insight into the areas of private equity, funds and growth companies. Since the beginning of July, we have been pleased to welcome Domenik Merdita (l.). Domenik is currently in the sixth semester of his business […]

Swiss TRI® Dental Implants is known for the state-of-the-art matrix® implant system without abutment for dental implants. matrix® is used in more than 50 countries worldwide. With the matrix® Digital Healing Abutment Library, TRI is now going one step further. This digital CAD library enables the rapid creation of patient-specific healing components and healing abutments […]

Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based sector specialist. The additional Managing Partner is an SHS home-grown and started his career at SHS in 2010. The shareholders […]

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]

Pneumology deals with diseases of the respiratory tract and is a speciality of internal medicine. The word is derived from the Greek: pneumo = lung, logia = study. In medicine, the subject of pulmonary medicine has received special attention in the last two years through COVID-19. The history of pneumology begins much earlier, of course. […]